Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07240805

Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies

Sponsor: BioSensics

View on ClinicalTrials.gov

Summary

Progressive supranuclear palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB) are severe neurodegenerative diseases that cause significant motor impairment impacting daily function. Researchers at BioSensics, Johns Hopkins School of Medicine, Massachusetts General Hospital and their collaborators aim to conduct an analytical and clinical validation of wearable-based digital health technologies for monitoring upper and lower limb function in PSP, MCI-LB and DLB that could enable frequent, at-home monitoring and be incorporated into future clinical trials.

Official title: Digital Health Technologies For Monitoring Disease Symptoms in Progressive Supranuclear Palsy and Dementia With Lewy Bodies

Key Details

Gender

All

Age Range

40 Years - 89 Years

Study Type

OBSERVATIONAL

Enrollment

60

Start Date

2026-06-15

Completion Date

2029-01-01

Last Updated

2026-04-09

Healthy Volunteers

No

Locations (2)

Johns Hopkins University School of Medicine

Lutherville, Maryland, United States

Massachusetts General Hospital

Boston, Massachusetts, United States